4.4 Review

Salpingectomy as a Means to Reduce Ovarian Cancer Risk

Journal

CANCER PREVENTION RESEARCH
Volume 8, Issue 5, Pages 342-348

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1940-6207.CAPR-14-0293

Keywords

-

Categories

Funding

  1. Fox Chase Cancer Center Ovarian SPORE grant [P50 CA083636]
  2. MD Anderson Uterine Cancer SPORE grant [P50 CA098258]
  3. Ovarian SPORE [P50 CA083639]
  4. NCI (Urban) [P50 CA083636]
  5. American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]

Ask authors/readers for more resources

Bilateral salpingo-oophorectomy (BSO) has become the standard-of-care for risk reduction in women at hereditary risk of ovarian cancer. Although this procedure significantly decreases both the incidence of and mortality from ovarian cancer, it affects quality of life, and the premature cessation of ovarian function may have long-term health hazards. Recent advances in our understanding of the molecular pathways of ovarian cancer point to the fallopian tube epithelium as the origin of most high-grade serous cancers (HGSC). This evolving appreciation of the role of the fallopian tube in HGSC has led to the consideration of salpingectomy alone as an option for risk management, especially in premenopausal women. In addition, it is postulated that bilateral salpingectomy with ovarian retention (BSOR), may have a public health benefit for women under going benign gynecologic surgery. In this review, we provide the rationale for salpingectomy as an ovarian cancer risk reduction strategy. (C) 2015 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available